-
1
-
-
0347320540
-
Actinic keratosis: Epidemiology and progression to squamous cell carcinoma
-
Lebwohl M. Actinic keratosis: Epidemiology and progression to squamous cell carcinoma. Br J Dermatol 2003, 149(suppl 66):31-33.
-
(2003)
Br J Dermatol
, vol.149
, Issue.SUPPL. 66
, pp. 31-33
-
-
Lebwohl, M.1
-
2
-
-
61449104877
-
Targeted therapies in squamous cell carcinoma of the head and neck
-
Gold K.A., Lee H.Y., Kim E.S. Targeted therapies in squamous cell carcinoma of the head and neck. Cancer 2009, 115:922-935.
-
(2009)
Cancer
, vol.115
, pp. 922-935
-
-
Gold, K.A.1
Lee, H.Y.2
Kim, E.S.3
-
3
-
-
17444410011
-
Immunohistochemical analysis of EGFR and HER-2 in patients with metastatic squamous cell carcinoma of the skin
-
Maubec E., Duvillard P., Velasco V., et al. Immunohistochemical analysis of EGFR and HER-2 in patients with metastatic squamous cell carcinoma of the skin. Anticancer Res 2005, 25:1205-1210.
-
(2005)
Anticancer Res
, vol.25
, pp. 1205-1210
-
-
Maubec, E.1
Duvillard, P.2
Velasco, V.3
-
4
-
-
38849091450
-
Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma
-
Ching S., Low I., Ng D., et al. Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma. Human Pathol 2008, 39:344-349.
-
(2008)
Human Pathol
, vol.39
, pp. 344-349
-
-
Ching, S.1
Low, I.2
Ng, D.3
-
5
-
-
0033874137
-
Expression of vascular endothelial growth factor induces an invasive phenotype in human squamous cell carcinomas
-
Detmar M., Velasco P., Richard L., et al. Expression of vascular endothelial growth factor induces an invasive phenotype in human squamous cell carcinomas. Am J Pathol 2000, 156:159-167.
-
(2000)
Am J Pathol
, vol.156
, pp. 159-167
-
-
Detmar, M.1
Velasco, P.2
Richard, L.3
-
6
-
-
77954447845
-
Novel therapeutic approaches to squamous cell carcinoma of the head and neck using biologically targeted agents
-
Harrington K.J., Kazi R., Bhide S.A., et al. Novel therapeutic approaches to squamous cell carcinoma of the head and neck using biologically targeted agents. Indian J Cancer 2010, 47:248-259.
-
(2010)
Indian J Cancer
, vol.47
, pp. 248-259
-
-
Harrington, K.J.1
Kazi, R.2
Bhide, S.A.3
-
7
-
-
77952842632
-
EGFR targeting drugs in the treatment of head and neck squamous cell carcinoma
-
Sundvall M., Karrila A., Nordberg J., et al. EGFR targeting drugs in the treatment of head and neck squamous cell carcinoma. Expert Opin Emerg Drugs 2010, 15:185-201.
-
(2010)
Expert Opin Emerg Drugs
, vol.15
, pp. 185-201
-
-
Sundvall, M.1
Karrila, A.2
Nordberg, J.3
-
8
-
-
77953392968
-
Molecular targeted therapies in head and neck cancer-An update of recent developments
-
Goerner M., Seiwert T.Y., Sudhoff H. Molecular targeted therapies in head and neck cancer-An update of recent developments. Head Neck Oncol 2010, 2:8.
-
(2010)
Head Neck Oncol
, vol.2
, pp. 8
-
-
Goerner, M.1
Seiwert, T.Y.2
Sudhoff, H.3
-
9
-
-
32144433159
-
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
-
Bonner J.A., Harari P.M., Giralt J., et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006, 354:567-578.
-
(2006)
N Engl J Med
, vol.354
, pp. 567-578
-
-
Bonner, J.A.1
Harari, P.M.2
Giralt, J.3
-
10
-
-
51649085865
-
Platinum-based chemotherapy plus cetuximab in head and neck cancer
-
Vermorken J.B., Mesia R., Rivera F., et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 2008, 359:1116-1127.
-
(2008)
N Engl J Med
, vol.359
, pp. 1116-1127
-
-
Vermorken, J.B.1
Mesia, R.2
Rivera, F.3
-
11
-
-
79955449561
-
-
Genmab, Accessed January 31, 2011
-
Genmab, Accessed January 31, 2011. http://www.genmab.com/Science%20And%20Research/Products%20in%20Development/Zalutumumab.aspx.
-
-
-
-
12
-
-
79955392008
-
-
Panitumumab, Accessed January 31, 2011
-
Panitumumab, Accessed January 31, 2011. http://www.cancer.gov/search/resultsclinicaltrials.aspx?protocolsearchid=8073033.
-
-
-
-
13
-
-
33845689865
-
Facial hypertrichosis induced by cetuximab, an anti-EGFR monoclonal antibody
-
Kerob D., Dupuy A., Reygagne P., et al. Facial hypertrichosis induced by cetuximab, an anti-EGFR monoclonal antibody. Arch Dermatol 2006, 142:1656-1657.
-
(2006)
Arch Dermatol
, vol.142
, pp. 1656-1657
-
-
Kerob, D.1
Dupuy, A.2
Reygagne, P.3
-
15
-
-
49149087647
-
Promising newer molecular-targeted therapies in head and neck cancer
-
Wang L.X., Agulnik M. Promising newer molecular-targeted therapies in head and neck cancer. Drugs 2008, 68:1609-1619.
-
(2008)
Drugs
, vol.68
, pp. 1609-1619
-
-
Wang, L.X.1
Agulnik, M.2
-
16
-
-
61449104877
-
Targeted therapies in squamous cell carcinoma of the head and neck
-
Gold K.A., Lee H.-Y., Kim E.S. Targeted therapies in squamous cell carcinoma of the head and neck. Cancer 2009, 115:922-935.
-
(2009)
Cancer
, vol.115
, pp. 922-935
-
-
Gold, K.A.1
Lee, H.-Y.2
Kim, E.S.3
-
17
-
-
79955399681
-
-
Sorafenib tosylate, Accessed January 31, 2011
-
Sorafenib tosylate, Accessed January 31, 2011. http://www.cancer.gov/search/ResultsClinicalTrials.aspx?protocolsearchid=8115987.
-
-
-
-
18
-
-
78049460226
-
Does basal cell carcinoma belong to the spectrum of sorafenib-induced epithelial skin cancers?
-
Degen A., Satzger I., Voelker B., et al. Does basal cell carcinoma belong to the spectrum of sorafenib-induced epithelial skin cancers?. Dermatology 2010, 221:193-196.
-
(2010)
Dermatology
, vol.221
, pp. 193-196
-
-
Degen, A.1
Satzger, I.2
Voelker, B.3
-
19
-
-
73949143686
-
Phase II study of sunitinib in recurrent or metastatic squamous cell carcinoma of the head and neck: GORTEC 2006-01
-
Michaelis J.P., Henry S., Zanetta S., et al. Phase II study of sunitinib in recurrent or metastatic squamous cell carcinoma of the head and neck: GORTEC 2006-01. J Clin Oncol 2010, 28:21-28.
-
(2010)
J Clin Oncol
, vol.28
, pp. 21-28
-
-
Michaelis, J.P.1
Henry, S.2
Zanetta, S.3
-
20
-
-
74549125912
-
Basal cell nevus syndrome: A brave new world
-
Goldberg L.H., Firoz B.F., Weiss G.J., et al. Basal cell nevus syndrome: A brave new world. Arch Dermatol 2010, 146:17-19.
-
(2010)
Arch Dermatol
, vol.146
, pp. 17-19
-
-
Goldberg, L.H.1
Firoz, B.F.2
Weiss, G.J.3
-
21
-
-
72949103044
-
Small-molecule modulators of the Sonic Hedgehog signaling pathway
-
Stanton B.Z., Peng L.F. Small-molecule modulators of the Sonic Hedgehog signaling pathway. Mol Biosyst 2010, 6:44-54.
-
(2010)
Mol Biosyst
, vol.6
, pp. 44-54
-
-
Stanton, B.Z.1
Peng, L.F.2
-
23
-
-
70349238733
-
Inhibition of the hedgehog pathway in advanced basal-cell carcinoma
-
Von Hoff D.D., LoRusso P.M., Rudin C.M., et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med 2009, 361:1164-1172.
-
(2009)
N Engl J Med
, vol.361
, pp. 1164-1172
-
-
Von Hoff, D.D.1
LoRusso, P.M.2
Rudin, C.M.3
-
24
-
-
70350496540
-
Smoothened mutation confers resistance to a hedgehog pathway inhibitor in medulloblastoma
-
Yauch R.L., Dijkgraaf G.J.P., Alicke B., et al. Smoothened mutation confers resistance to a hedgehog pathway inhibitor in medulloblastoma. Science 2009, 326:572-574.
-
(2009)
Science
, vol.326
, pp. 572-574
-
-
Yauch, R.L.1
Dijkgraaf, G.J.P.2
Alicke, B.3
-
26
-
-
77950647110
-
Small-molecule inhibitors of the hedgehog signaling pathway as cancer therapeutics
-
Peukert S., Miller-Moslin K. Small-molecule inhibitors of the hedgehog signaling pathway as cancer therapeutics. Chemmedchem 2010, 5:500-512.
-
(2010)
Chemmedchem
, vol.5
, pp. 500-512
-
-
Peukert, S.1
Miller-Moslin, K.2
-
27
-
-
34648832068
-
Dermatofibrosarcoma protuberans: Recent clinical progress
-
McArthur G.A. Dermatofibrosarcoma protuberans: Recent clinical progress. Ann Surg Oncol 2007, 14:2876-2886.
-
(2007)
Ann Surg Oncol
, vol.14
, pp. 2876-2886
-
-
McArthur, G.A.1
-
28
-
-
77950469922
-
Imatinib mesylate in advanced dermatofibrosarcoma protuberans: Pooled analysis of two phase II clinical trials
-
Rutkowski P., Von Glabbeke M., Rankin C.J., et al. Imatinib mesylate in advanced dermatofibrosarcoma protuberans: Pooled analysis of two phase II clinical trials. J Clin Oncol 2010, 28:1772-1779.
-
(2010)
J Clin Oncol
, vol.28
, pp. 1772-1779
-
-
Rutkowski, P.1
Von Glabbeke, M.2
Rankin, C.J.3
-
29
-
-
79751475654
-
Treatment of advanced dermatofibrosarcoma protuberans with imatinib mesylate with or without surgical resection
-
Rutkowski P., Debiec-Rychter M., Nowecki Z., et al. Treatment of advanced dermatofibrosarcoma protuberans with imatinib mesylate with or without surgical resection. J Eur Acad Dermatol Venereol 2011, 25:264-270.
-
(2011)
J Eur Acad Dermatol Venereol
, vol.25
, pp. 264-270
-
-
Rutkowski, P.1
Debiec-Rychter, M.2
Nowecki, Z.3
-
30
-
-
14144256775
-
Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225
-
McArthur G.A., Demetri G.D., van Oosterom A., et al. Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225. J Clin Oncol 2005, 23:866-873.
-
(2005)
J Clin Oncol
, vol.23
, pp. 866-873
-
-
McArthur, G.A.1
Demetri, G.D.2
van Oosterom, A.3
-
31
-
-
77953700949
-
Imatinib mesylate as a preoperative therapy in dermatofibrosarcoma: Results of a multicenter phase II study of 25 patients
-
Kerob D., Procher R., Verola O., et al. Imatinib mesylate as a preoperative therapy in dermatofibrosarcoma: Results of a multicenter phase II study of 25 patients. Clin Cancer Res 2010, 16:3288-3295.
-
(2010)
Clin Cancer Res
, vol.16
, pp. 3288-3295
-
-
Kerob, D.1
Procher, R.2
Verola, O.3
-
32
-
-
67650799353
-
Neoadjuvant imatinib therapy for dermatofibrosarcoma protuberans
-
Han A., Chen E.H., Niedt G., et al. Neoadjuvant imatinib therapy for dermatofibrosarcoma protuberans. Arch Dermatol 2009, 145:792-796.
-
(2009)
Arch Dermatol
, vol.145
, pp. 792-796
-
-
Han, A.1
Chen, E.H.2
Niedt, G.3
|